AI Heart Monitor for New Atrial Fibrillation Detection
Part of Heart & circulation clinical trials.
This trial uses a special long-term heart monitor (one wire) that uses artificial intelligence to find new cases of atrial fibrillation, a type of irregular heartbeat that can increase stroke risk. If you're 60 or older and haven't had AF before, this study could help catch it early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 years old or older.
- You have never been diagnosed with atrial fibrillation before.
- You do not have a pacemaker or an implanted heart defibrillator.
- You are able to understand the study and agree to take part.
- You are expected to live at least one more year (no serious illnesses like advanced cancer or kidney failure).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if an electronic blood pressure monitor can detect atrial fibrillation, a common heart rhythm problem, in people aged 60 and older. It aims to make screening easier and more accessible.
This trial tests whether using an artificial intelligence (AI) system to read your electrocardiogram (ECG, a heart rhythm test) can better evaluate your heart's structure and function, helping manage atrial fibrillation (AF). You may qualify if you have AF and need an echocardiogram (ultrasound of the heart).
This trial uses an artificial intelligence system to analyze your electrocardiogram (ECG) results and alert your care team if you might be developing atrial fibrillation. It aims to catch this common heart rhythm problem early, so you can get treatment sooner.
This trial tests a blood pressure monitor that can also detect atrial fibrillation (an irregular heartbeat). You may join if you are 22 or older, have an average-sized arm, and either have been diagnosed with AF or have never had it — as long as you don't have a pacemaker or defibrillator.
This trial uses a simple, handheld ECG device (like a small card) to check your risk for atrial fibrillation, a common irregular heartbeat. You'll record short heart tracings at home, and the study team will review them to find hidden risk factors.
This study is testing if an AI program can help doctors choose better treatments for atrial fibrillation (AF). It is for people who were recently diagnosed with AF and have noticeable symptoms.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.